Volume 22, Number 7—July 2016
CME ACTIVITY - Synopsis
Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States
Table 3
Source | Time of sample collection | rRT-PCR | Ebola antibodies | Immunohistochemistry |
---|---|---|---|---|
Maternal blood | 1 week before delivery | Negative | IgG (1:1,600); IgM not detected | NA |
Cord blood | At delivery | Negative | IgG (1:1,600); IgM not detected | NA |
Amniotic fluid | At delivery | Negative | IgG; IgM not detected | NA |
Vaginal swab sample | At delivery | Negative | NA | NA |
Neonate ear swab sample | At delivery | Negative | NA | NA |
Neonate oral swab sample | At delivery | Negative | NA | NA |
Placenta | At delivery | Negative | NA | Negative for Ebola antigen |
Umbilical cord | At delivery | NA | NA | Negative for Ebola antigen |
Colostrum | 1 day after delivery | Negative | IgG and IgM not detected | NA |
*NA, not applicable; rRT-PCR, real-time reverse transcription PCR.
Page created: May 19, 2016
Page updated: June 15, 2016
Page reviewed: June 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.